A mouse model of transplacental cocaine exposure: Clinical implications for exposed infants and children

Annals of the New York Academy of Sciences

Volumn 846, Issue , 1998, Pages 248-261

  Kosofsky, Barry E ^a   Wilkins, Aaron S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; PHENTOLAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN DEVELOPMENT; CONDITIONED REFLEX; CONFERENCE PAPER; CONTROLLED STUDY; EMBRYO; FEMALE; GROWTH RETARDATION; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRENATAL DRUG EXPOSURE;

ANIMALIA; RODENTIA;

EID: 0031905049     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09742.x     Document Type: Article

References (71)

1. National pregnancy and health survey. 1995. A National Institute on Drug Abuse report. National Institutes of Health, Department of Health and Human Services. Washington, DC. Government Printing Office.
2. DOW-EDWARDS, D.L. 1991. Cocaine effects on fetal development: A comparison of clinical and animal research findings. Neurotoxicol. Teratol. 13:347-352.
3. GINORAS, J.L., D.E. WEESE-MAYER, R.F. HUME, JR. α K.J. O'DONNELL. 1992. Cocaine and development: Mechanisms of fetal toxicity and neonatal consequences of prenatal cocaine exposure. Early Human Dev. 31: 1-24.
4. GONZALEZ, N.M. α M. CAMPBELL. 1994. Cocaine babies: Does prenatal exposure to cocaine affect development? J. Am. Acad. Child Adolesc. Psychiatry 33: 16-19.
5. KOSOFSK.Y, B.E. 1991. The effect of cocaine on developing human brain. In Methodologie Issues in Controlled Studies on Effects of Prenatal Exposure to Drugs of Abuse. M.M. Kilbey α K. Asghar, Eds. Washington, DC. NIDA Research Monograph #114:128-143.
6. LUTIGER, B., K. GRAHAM, T.R. EINARSON α G. KOREN. 1991. Relationship between gestational cocaine use and pregnancy outcome: A meta-analysis. Teratology 44:405-414.
7. MAYES, L.C., R.H. GRANGER, M.H. BORNSTEIN α B. ZUCKERMAN. 1992. The problem of prenatal cocaine exposure: A rush to judgement. JAMA 267:406-408.
8. ROBINS, L.N. α J.L. MILLS. 1993. Effects of in utero exposure to street drugs. Am. J. Public Health 83:3-32.
9. VOLPE, J.J. 1992. Effect of cocaine use on the fetus. N. Engl. J. Med. 327:399-407.
10. ZUCKERMAN, B. α K. BRESNAHAN. 1991. Developmental and behavioral consequences of prenatal drug and alcohol exposure. Pediatr. Clin. North Am. 38:1387-1406.
11. CIIIRIBOOA, C.A. 1996. Cocaine and the fetus: Methodological issues and neurological consequences. In Prenatal Cocaine Exposure. R.J. Konkol α G.D. Olsen, Eds. : 1-21. Boca Raton. CRC Press.
12. CHASNOFF, I.J., D.R. GRIFFITH, S. MACGREGOR, K. DIRKES α K.A. BURNS. 1989. Temporal patterns of cocaine use in pregnancy. JAMA 261: 1741-1744.
13. CHASNOFF, I.J., D.R. GRIFFITH, C. FREIER α J. MURRAY. 1992. Cocaine/polydnig use in pregnancy: Two-year follow-up. Pediatrics 89:284-289.
14. MIROCHNICK, M., D.A. FRANK, H. CABRAL, A. TURNER α B. ZUCKERMAN. 1995. Relation between meconium concentration of the cocaine metabolite benzoylecgonine and fetal growth. J. Pediatr. 126:636-638.
15. LESTER, B.M., L. LAGASSE, K. FREIER α S. BRUNNER. 1996. Studies of cocaine-exposed human infants. In Behavioral Studies of Drug-Exposed Offspring: Methodological Issues in Human and Animal Research. C.L. Wetherington, V.L. Smeriglio α L.P. Finnegan, Eds. : 164-210. U. S. Government Printing Office. Washington, DC.
16. DELANEY-BLACK, V., C. COVINGTON, E. OSTREA, JR., et al. 1996. Prenatal cocaine and neonatal outcome: Evaluation of dose-response relationship. Pediatrics 98: 735-740.
17. DELANEY-BLACK, V. et al. Ann. N.Y. Acad. Sei., this volume.
18. JACOBSON, S.W., J.L. JACOBSON, R.J. SOKOL, S.S. MARTIER α L.M. CHIODO. 1996. New evidence for neurobehavioral effects of in utero cocaine exposure. J. Pediatr. 129: 581-589.
19. AZUMA, S.D. α I J. CHASNOFF. 1993. Outcome of children prenatally exposed to cocaine and other drugs: A path analysis of three-year data. Pediatrics 92: 396-402.
20. CHIRIBOGA, C.A. 1993. Fetal effects. Neurol. Clin. North Am. 11:707-729.
21. CHIRIBOGA, C.A., M. VIBBERT, R. MALOUF et al. 1995. Neurological correlates of fetal cocaine exposure: Transient hypertonia of infancy and early childhood. Pediatrics 961070-1077. '
22. MAYES, L.Q, M.H. BORNSTEIN, K. CHAWARSKA'& R.H. GRANGER. 1995. Information processing and developmental assessments in 3-month-old infants exposed prenatally to cocaine. Pediatrics 95: 539-545.
23. DAVIS, E., I. FENOY & D. LARAQUE. 1992. Autism and developmental abnormalities in children with perinatal cocaine exposure. J. Nat. Med. Assoc. 84: 315-319.
24. NULMAN, I., J. ROVET, D. ALTMANN, C. BRADLEY, T. EINARSON & G. KOREN. 1994. Neurodevelopment of adopted children exposed in utero to cocaine. Canad. M.A.J. 151: 1592-1597.
25. MENTIS, M. & K. LUNDGREN. 1995. Effects of prenatal exposure to cocaine and associated risk factors on language development. J. Speech Hearing Res. 38:1303-1318.
26. MAYES, L. et al. Ann. N.Y. Acad. Sei., this volume.
27. CHURCH, M.W. & H.C. RAUCH. 1992. Prenatal cocaine exposure in the laboratory mouse: Effects on maternal water consumption and offspring outcome. Neurotoxicol. Teratol. 14: 313-319.
28. GRESSENS, P., F. GOFFLOT, G. VAN MAELE-FABRY et al. 1992. Early neurogenesis and teratogenesis in whole mouse embryo cultures. Histochemical, immunocytological and ultrastructural study of the premigratory neuronal-glial units in normal mouse embryo and in mouse embryos influenced by cocaine and retinoic acid. J. Neuropathol. Exp. Neurol. 51:206-219.
29. HENDERSON, M.G. & B.A. McMiLLEN. 1990. Effects of prenatal exposure to cocaine or related drugs on rat developmental and neurological indices. Brain Res. Bull. 24: 207-212.
30. 1A receptor agonist. Neurosci. Lett. 170:141-144.
31. HEYSER, C.J., W.-J. CHEN, J. MILLER, N.E. SPEAR & L.P. SPEAR. 1990. Prenatal cocaine exposure induces deficits in pavlovian conditioning and sensory preconditioning among infant rat pups. Behav. Neurosci. 10-4:955-963.
32. WIGGINS, R.C. & B. Ruiz. 1990. Development under the influence of cocaine. I. A comparison of the effects of daily cocaine treatment and resultant undernutrition on pregnancy and early growth in a large population of rats. Metabolic Brain Dis. 5: 85-99.
33. KUNKO, P.M., D. MOVER & S.E. ROBINSON. 1993. Intravenous gestational cocaine in rats: Effects on offspring development and weanling behavior. Neurotoxicol. Teratol. 15:335-344.
34. SOBRIAN, S.K., L.E. BURTON, N.L. ROBINSON et al. 1989. Neurobehavioral and immunological effects of prenatal cocaine exposure in rat. Pharmacol. Biochem. Behav. 35: 617-629.
35. HUTCHINGS, D.E., T.A. Fico & D.L. DOW-EDWARDS. 1989. Prenatal cocaine: Maternal toxicity, fetal effects and locomotor activity in rat offspring. Neurotoxicol. Teratol. 11:65-69.
36. SMITH, R.F., K.M. MATTRAN, M.F. KURKJIAN & S.L. KURTZ. 1989. Alterations in offspring behavior induced by chronic prenatal cocaine dosing. Neurotoxicol. Teratol. 11:35-
37. CHURCH, M.W., P.A. HOLMES, G.W. OVERBECK, J.P. TLAK & C.S. ZAJAC. 1991. Interactive effects of prenatal alcohol and cocaine exposures on postnatal mortality, development and behavior in the Long-Evans rat. Neurotoxicol. Teratol. 13: 377-386.
38. GOODWIN, G.A., C.J. HEYSER, C.A. MOODY et al. 1992. A fostering study of the effects of prenatal cocaine exposure: II. Offspring behavioral measures. Neurotoxicol. Teratol. 14: 423-432.
39. KOSOFSKY, B.E., A.S. WILKINS, P. GRESSENS & P. EVRARD. 1994. Transplacental cocaine exposure: A mouse model demonstrating neuroanatomic and behavioral abnormalities. J. Child Neurol. 9:234-241.
40. SPEAR, L.P., CL. KIRSTEIN, J. BELL et al. 1989. Effects of prenatal cocaine exposure on behavior during the early postnatal period. Neurotoxicol. Teratol. 11: 57-63.
41. SPEAR, L.P. 1995. Neurobehavioral consequences of gestational cocaine exposure: A comparative analysis. In Advances in Infancy Research, Vol. 9. C. Rovee-Collier & L.P. Lipsitt, Eds. : 55-105. Ablex. Norwood.
42. HEYSER; C.J., N.E. SPEAR & L.P. SPEAR. 1992. Effects of prenatal exposure to cocaine on conditional discrimination learning in adult rats. Behav. Neurosci. 106: 837-845.
43. BILITZKE, P.J. & M.W. CHURCH. 1992. Prenatal cocaine and alcohol exposures affect rat behavior in a stress test (the Porsolt swim test). Neurotoxicol. Teratol. 14: 359-364.
44. HEYSER, C.J., J.S. MILLER, N.B. SPEAR & L.P. SPEAR. 1992. Prenatal exposure to cocaine disrupts cocaine-induced conditioned place preference in rats. Neurotoxicol. Teratol. 14: 57-64.
45. MOLINA, VA., J.M. WAGNER & L.P. SPEAR. 1994. The behavioral response to stress is altered in adult rats exposed prenatally to cocaine. Physiol. Behav. 55:941-945.
46. KAMIN, L.J. 1969. Predictability, surprise, attention and conditioning. In Punishment and Aversive Behavior. B.A. Campbell & R.M. Church, Eds. Appleton-Century-Crofts. New York.
47. CRIDER, A., L. BLOCKEL & PR. SOLOMON. 1986. A selective attention deficit in the rat following induced dopamine receptor supersensitivity. Behav. Neurosci. 100: 315-319.
48. MACKINTOSH, N.J. 1975. A theory of attention: Variations in the associability of stimuli with reinforcement. Psychol. Rev. 82:276-298.
49. CRIDER, A., P.R. SOLOMON & M.A. McMAHON. 1982. Disruption of selective attention in the rat following chronic rf-amphetamine administration: Relationship to schizophrenic attention disorder. Biol. Psychiatry 17: 351-361.
50. BURCHFIELD, D.J., E.M. GRAHAM, R.M. ABRAMS & K.J. GERHARDT. 1990. Cocaine alters behavioral states in fetal sheep. Dev. Brain Res. 56:41-45.
51. ANDERSON-BROWN, T., T.A. SLOTKIN & F.J. SEIDLER. 1990. Cocaine acutely inhibits DNA synthesis in developing rat brain regions: Evidence for direct actions. Brain Res. 537: 197-202.
52. FANTEL, A.G., C.V. BARBER, M.B. CARDA, R.W. TUMBIC & B. MACKLER. 1992. Studies of the role of ischemia/reperfusion and Superoxide anion radical production in the teratogenicity of cocaine. Teratology
53. HOYME, H.E., K.L. JONES, S.D. DIXON et al. 1990. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 85:743-747.
54. KOEGLER, S.M., F.J. SEIDLER, J.R. SPENCER & T.A. SLOTKIN. Ischemia contributes to adverse effects of cocaine on brain development: Suppression of ornithine decarboxylase activity in neonatal rat. Brain Res. Bull. 27:829-834.
55. KONKOL, R.J., L.J. MURPHEY, D.M. FEKRIERO, D.A. DEMPSEY & G.D. OLSEN. Cocaine metabolites in the neonate: Potential for toxicity. J. Child Neurol. 9:242-248.
56. KOSOFSKY, B.E. & S.E. HYMAN. The ontogeny of immediate early gene response to cocaine: A molecular analysis of the effects of cocaine on developing brain. In Immediate Early Gene Activation by Drugs of Abuse. R.G. Grzanna & R.M. Brown, Eds. : 161-171. NIDA Research Monograph #125. Washington, DC.
57. MURPHY, E.H., J.G. HAMMER, M.D. SCHUMANN et al. 1995. The rabbit as a model for studies of in utero cocaine exposure. Lab. Anim. Sei. 45:163-168.
58. SEIDLER, F.J., S.W. TEMPLE, E.G. McCooK & T.A. SLOTKIN. 1995. Cocaine inhibits central noradrenergic and dopaminergic activity during the critical developmental period in which catacholamines influence cell development. Dev. Brain Res. 85:48-53.
59. THADANI, P.V. 1995. Biological mechanisms and perinatal exposure to abused drugs. Synapse 19:228-232.
60. SPEAR, L.P. 1993. Missing pieces of the puzzle complicate conclusions about cocaine's neurobehavioral toxicity in clinical populations: Importance of animal models. Neurotoxicol. Teratol. 15: 307-309.
61. JONES, L., I. FISCHER & P. LEVITT. 1996. Nonuniform alteration of dendritic development in the cerebral cortex following prenatal cocaine exposure. Cerebr. Cortex 6:431-445.
62. RONNEKLEIV, O.K. & B.R. NAYLOR. 1995. Chronic cocaine exposure in the fetal rhesus monkey: Consequences for early development of dopamine neurons. J. Neurosci. 15: 7330-7343.
63. LIDOW, M.S. 1995. Prenatal cocaine exposure adversely affects development of the primate cerebral cortex. Synapse 21: 332-341.
64. WOODS, J.R., M.A. PLESSINGER & K.E. CLARK. 1987. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA 257:957-961.
65. LAUDER, J.M. 1993. Neurotransmitters as growth regulatory signals: Role of receptors and second messages. Trends Neurosci. 16: 233-240.
66. POSNER, M.I. & S.E. PETERSON. 1990. The attention system of the human brain. Annu. Rev. Neurosci. 13:25-42.
67. HIEBLE, J.P., A.J. NICHOLS, S.Z. LANCER & R.R. RUFFOLO, JR. 1995. Pharmacology of the sympathetic nervous system. In Principles of Pharmacology. P.L. Munson, R.A. Mueller, G.R. Breese, Eds. 121-144. Chapman and Hall. New York.
68. WILKINS, A.S., L.M. GEKOVA, W. POSTEN & B.E. KOSOFSKY. 1998. Transplacental cocaine exposure 1: A rodent model. Neurotoxicol. Teratol. 20: in press.
69. WILKINS, A.S., K. JONES & B.E. KOSOFSKY. 1998. Transplacental cocaine exposure 2: Effects of cocaine dose and gestational timing. Neurotoxicol. Teratol. 20: in press.
70. WILKINS, A.S., J.A. MAROTA, E. TABIT & D.E. KOSOFSKY. 1998. Transplacental cocaine exposure 3: Mechanisms underlying altered brain development. Neurotoxicol. Teratol. 20: in press
71. GRESSENS, P., B.E. KOSOFSKY & P. EVRARD. 1992. Cocaine-induced disturbances of corticogenesis in the developing murine brain. Neurosci. Lett. 140: 13-116.